Disease | premature ovarian failure |
Comorbidity | C0302592|cervical ca |
Sentences | 1 |
PubMedID- 25405572 | Conclusions: fewer than half of cervical cancer survivors with therapy-induced early menopause used ht at or close to the recommended dose, and the use decreased during follow-up. |
Page: 1